Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Emcure Pharma IPO and LIC IPO.
Emcure Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while LIC IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
| Emcure Pharma IPO | LIC IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | Mainline | Mainline |
| Issue Type | IPO | IPO |
| Process Type | Book Built Issue | Book Built Issue |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Kotak Mahindra Capital Company Limited Axis Capital Limited Jefferies India Private Limited J.P. Morgan India Private Limited |
Axis Capital Limited Bofa Securities India Limited Citigroup Global Markets India Private Limited Goldman Sachs (India) Securities Private Limited ICICI Securities Limited J.P. Morgan India Private Limited Jm Financial Limited Kotak Mahindra Capital Company Limited Nomura Financial Advisory And Securities (India) Pvt Ltd SBI Capital Markets Limited |
| Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
|
| Anchor Investor | Anchor Investor |
|
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Emcure Pharma IPO is whereas the issue size of the LIC IPO is up to ₹21,008.48 Cr. The final issue price of Emcure Pharma IPO is and of LIC IPO is ₹949.00 per share.
| Emcure Pharma IPO | LIC IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹902.00 per share | |
| Issue Price (Upper) | ₹949.00 per share | |
| Issue Price (Final) | ₹949.00 per share | |
| Discount (Retail) | ₹45.00 per share | |
| Discount (Employee) | ₹45.00 per share | |
| Market Lot Size | 15 shares | |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | up to ₹800.00 Cr | |
| OFS Issue Size | 1,36,78,839 shares | 22,13,74,920 shares |
| OFS Issue Size (Amount) | up to ₹21,008.48 Cr | |
| Issue Size Total | 22,13,74,920 shares | |
| Issue Size Total (Amount) | up to ₹21,008.48 Cr |
Emcure Pharma IPO opens on , while LIC IPO opens on May 04, 2022. The closing date of Emcure Pharma IPO and LIC IPO is , and May 09, 2022, respectively.
| Emcure Pharma IPO | LIC IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | May 04, 2022 | |
| Issue Close | May 09, 2022 | |
| Basis Of Allotment (Tentative) | May 12, 2022 | |
| Initiation of Refunds (Tentative) | May 13, 2022 | |
| Credit of Share (Tentative) | May 16, 2022 | |
| Listing date (Tentative) | May 17, 2022 | |
| Anchor Lockin End date 1 | Jun 11, 2022 | |
| Anchor Lockin End date 2 | Aug 10, 2022 |
Emcure Pharma IPO P/E ratio is , as compared to LIC IPO P/E ratio of 201.91.
| Emcure Pharma IPO | LIC IPO | ||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial |
|
|
|||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100% | ||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 96.50% | ||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 201.91 | ||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹600242.28 Cr. | ||||||||||||||||||||||||||||||||||||||||||||
| ROE | |||||||||||||||||||||||||||||||||||||||||||||
| ROCE | |||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||
| EPS | |||||||||||||||||||||||||||||||||||||||||||||
| RoNW | |||||||||||||||||||||||||||||||||||||||||||||
In the Emcure Pharma IPO retail investors (RII) are offered while in LIC IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Emcure Pharma IPO and 3,95,31,236 shares in LIC IPO.
| Emcure Pharma IPO | LIC IPO | |
|---|---|---|
| Anchor Investor Reserveration | 5,92,96,853 shares | |
| Market Maker Reserveration | ||
| QIB | 3,95,31,236 shares | |
| NII | 2,96,48,427 shares | |
| RII | 6,91,79,663 shares | |
| Employee | 15,81,249 shares | |
| Others | ||
| Total | 16,20,78,067 shares |
Emcure Pharma IPO subscribed in total, whereas LIC IPO subscribed 2.95x.
| Emcure Pharma IPO | LIC IPO | |
|---|---|---|
| QIB (times) | 2.83x | |
| NII (times) | 2.91x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.99x | |
| Employee (times) | 4.40x | |
| Other (times) | 6.12x | |
| Total (times) | 2.95x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
